Marksans Pharma informs about daily report regarding the equity shares bought back

02 Nov 2022 Evaluate

With reference to the Buyback of equity shares of Re 1 each of the company in terms of Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018 (‘SEBI Buyback Regulations’) through open market using the Stock Exchanges Mechanism (‘Buyback’), Marksans Pharma has submitted the daily report pursuant to Regulation 18 of the SEBI Buyback Regulations regarding the Equity Shares bought back on November 1, 2022.

The above information is a part of company’s filings submitted to BSE.



Marksans Pharma Share Price

163.10 -6.85 (-4.03%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×